Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Professor of Cell Biology, Erasmus MC, and Founder of Harbour Antibodies BV at Erasmus MC and Harbour BioMed BV
Dr. Frank Grosveld founded Harbour Antibodies in 2006 at Erasmus MC (Rotterdam, the Netherlands). He and his team were responsible for the development and patent of two strains of transgenic mice technology: (i) H2L2: traditional two heavy chain and two light chains; and (ii) HCAb: novel "heavy chain only.” Dr. Grosveld studied biochemistry at the University of Amsterdam and obtained his PhD from McGill University. He has started several companies and is a Professor of Cell Biology and the Biomics Center at Erasmus MC. His group has filed considerable number of patents in the area of Immunology and Genomics and has closely collaborated with industrial partners. Dr. Grosveld is a fellow of the Royal Society and a member of the Dutch Academy of Science, and a member of the Scientific Advisory Board for Harbour BioMed.